STOCKHOLM, Aug. 10, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) and Innate Pharma SA (Euronext Paris: IPH) (NASDAQ: IPHA) ("Innate" or the "Company") today announced that they have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory...
Hence then, the article about sobi enters strategic partnership with innate pharma to license lacutamab in t cell lymphoma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma )
Also on site :
- Jim Morrison Said His Parents Were Dead. 62 Years Ago This Week, His Father May Have Started the Vietnam War. Morrison Defined Its Destruction.
- 1969 Hit, Reimagined by Reba McEntire Decades Later, Ranked Among ‘Greatest Country Songs of All Time’
- Second PIC/S GMP Certification .. Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections